Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut)-Reference-Cited by-同舟云学术

Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut)

Published:2014-02 Issue:2 Volume:25 Page:212-218
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Modest Dominik P.,Schulz Christoph,von Weikersthal Ludwig F.,Quietzsch Detlef,von Einem Jobst C.,Schalhorn Andreas,Vehling-Kaiser Ursula,Laubender Rüdiger P.,Giessen Clemens,Stintzing Sebastian,Heinemann Volker

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference6 articles.

1. One colon lumen but two organs.;Carethers;Gastroenterology,2011

2. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location.;Bufill;Ann Intern Med,1990

3. Two colons-two cancers: paradigm shift and clinical implications.;Gervaz;J Surg Oncol,2004

4. Colorectal cancers choosing sides.;Albuquerque;Biochim Biophys Acta,2011

5. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival.;Benedix;Dis Colon Rectum,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI;ESMO Open;2024-09

2. Impact of Primary Tumor Sidedness on Prognosis and Anti-EGFR Antibody Efficacy in BRAF-Mutant Metastatic Colorectal Cancer: A Pooled Analysis of AIO Studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI;2024

3. Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location;European Journal of Cancer;2023-02

4. Deep learning‐based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer;Journal of Cachexia, Sarcopenia and Muscle;2022-12-21

5. Evaluating the value of tumor length times width in colorectal adenocarcinoma with different tumor locations;Medicine;2022-06-30